Literature DB >> 3613022

Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly.

M A O'Rourke, J R Feussner, P Feigl, J Laszlo.   

Abstract

Lung cancer increases in incidence with increasing age and is the leading cause of cancer death in the United States. While mass screening for lung cancer is not indicated, selective screening of high-risk target groups may be beneficial. We tested the hypothesis that lung cancer is initially seen at a less advanced stage with increasing age using incidence cases (N = 22,874) from the Centralized Cancer Patient Data System. The percent of lung cancer patients with local stage disease increased from 15.3% of those aged 54 years or younger, to 19.2% of those aged 55 to 64 years, to 21.9% of those aged 65 to 74 years, and to 25.4% of those aged 75 years or older. The percent with distant stage decreased from 48.7%, to 44.5%, to 40.3%, and to 36.7% for the same age groups, respectively. These age-stage trends persisted in subgroup analysis by sex, race, and histological subtype. Furthermore, analysis of 6332 patients who underwent surgical staging showed a greater likelihood of local stage disease with increasing age. Thus, compared with the young, the group aged 65 years or older is at a greater risk for lung cancer and has a higher proportion of lung cancer initially seen at local stage. The efficacy of selective screening for lung cancer in this target group warrants additional study.

Entities:  

Mesh:

Year:  1987        PMID: 3613022

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  20 in total

1.  Age and the treatment of lung cancer.

Authors:  J S Brown; D Eraut; C Trask; A G Davison
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

2.  Deceleration in the age pattern of mortality at older ages.

Authors:  S Horiuchi; J R Wilmoth
Journal:  Demography       Date:  1998-11

Review 3.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 4.  Lung cancer health disparities.

Authors:  Bríd M Ryan
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

5.  Elderly patients with squamous lung carcinoma: faring better or worse?

Authors:  George Pentheroudakis; Konstantinos Neanidis; Lida Kostadima; George Fountzilas; Nicholas Pavlidis
Journal:  Support Care Cancer       Date:  2006-02-25       Impact factor: 3.603

Review 6.  Treatment and outcomes for elderly patients with small cell lung cancer.

Authors:  R J Stephens; D H Johnson
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 7.  Epidemiology and management of common pulmonary diseases in older persons.

Authors:  Kathleen M Akgün; Kristina Crothers; Margaret Pisani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-15       Impact factor: 6.053

Review 8.  Lung cancer in elderly patients.

Authors:  Federico Venuta; Daniele Diso; Ilaria Onorati; Marco Anile; Sara Mantovani; Erino A Rendina
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

9.  Association of carcinogenic polycyclic aromatic hydrocarbon emissions and smoking with lung cancer mortality rates on a global scale.

Authors:  Oleksii Motorykin; Melissa M Matzke; Katrina M Waters; Staci L Massey Simonich
Journal:  Environ Sci Technol       Date:  2013-03-08       Impact factor: 9.028

Review 10.  The aged patient with lung cancer. Management recommendations.

Authors:  V Zagonel; U Tirelli; D Serraino; G Lo Re; M C Merola; M Mascarin; M G Trovò; A Carbone; S Monfardini
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.